tiprankstipranks
pc:calli

Callio Therapeutics

Seattle, Washington, United States
calliotx.com
Callio Therapeutics is a biotechnology company focused on developing multi-payload antibody-drug conjugate technology to enhance therapeutic outcomes for cancer patients. By overcoming the limitations of existing single-payload therapies, Callio aims to maximize the therapeutic benefits of its innovative programs.

Leadership & Board

Key Executives
CEO & Co-FounderPiers Ingram
CSO & Co-FounderJerome Boyd-Kirkup
CMONaomi Hunder
CBOAngele Maki
Current Number of Employees17
Current LinkedIn Followers3,632

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$187M
Total Amount Raised$187M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$187M
Latest Funding Amount$187M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Callio Therapeutics had 17 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
17Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Callio Therapeutics had 3,632 followers as of April 6, 2026. The number of followers increased by 39 (1.09%) week-over-week.
3,632Latest Followers Count
39(1.09%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Mar 03, 2025
Series A
$187.00M

Investors

Investor Name
Funding Round

Related News and Analysis